Login to Your Account



Verona raises £14M for COPD, severe chronic cough candidates

By Nuala Moran
Staff Writer

Friday, March 7, 2014
LONDON – Verona Pharma plc is riding the wave of investor exuberance for biotech, attracting U.S. and UK institutional investors to take up new shares to the value of £14 million (US$23.4 million).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription